From May 16 to 19, 2024, the Australian Trade and Investment Commission (Austrade) led a delegation of 16 leading Australian clinical trial providers to the DIA China Annual Meeting 2024, showcasing Australia’s strengths and services in drug development, technological innovation, and clinical trials. As one of 16 Australian companies, JP Medical Consulting made its debut at DIA with information on Australia’s top team of academicians and expert advisors.